Tari A King

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Positive Breast Cancer

Artificial Intelligence

Sentinel Lymph Node

Top Venues

Breast cancer research and treatment

Annals of surgical oncology

CA: a cancer journal for clinicians

This page only lists publications with an associated author ORCID identifier.

Publications

Ko Un Park, Stuart Lipsitz, Laura S Dominici, Filipa C Lynce, Christina A Minami, Faina Nakhlis, Adrienne G Waks, Laura E Warren, Nadine Eidman, Jeannie Frazier, Lourdes Hernandez, Carla Leslie, Susan Rafte, Delia Stroud, Joel S Weissman, Tari A King, Elizabeth A Mittendorf
Generative artificial intelligence as a source of breast cancer information for patients: Proceed with caution. Cancer (2024)
Anna Weiss, Olga Martínez-Sáez, Adrienne G Waks, Alison Laws, Monica McGrath, Paolo Tarantino, Leah H Portnow, Eric Winer, María Rey, Marta Tapia, Aleix Prat, Ann H Partridge, Sara M Tolaney, Juan M Cejalvo, Elizabeth A Mittendorf, Tari A King
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. Cancer (2023)
Tal Sella, Olga Kantor, Anna Weiss, Ann H Partridge, Otto Metzger, Tari A King
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy. Breast cancer research and treatment 194 (3) (2022)
Brittany Bychkovsky, Alison Laws, Fisher Katlin, Marybeth Hans, Mary Knust Graichen, Lydia E Pace, Rochelle Scheib, Judy E Garber, Tari A King
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast cancer research and treatment 193 (2) (2022)
Olga Kantor, Anna Weiss, Harold J Burstein, Elizabeth A Mittendorf, Tari A King
Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes. Annals of surgical oncology 29 (12) (2022)
Olga Kantor, Anna Weiss, Harold J Burstein, Elizabeth A Mittendorf, Tari A King
ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes. Annals of surgical oncology 29 (12) (2022)
Jennifer R Bellon, Harold J Burstein, Elizabeth S Frank, Elizabeth A Mittendorf, Tari A King
Multidisciplinary considerations in the treatment of triple-negative breast cancer. CA: a cancer journal for clinicians 70 (6) (2020)
Anna Weiss, Samantha Grossmith, Danielle Cutts, Sage A Mikami, Johanna A Suskin, Mary Knust Graichen, Negui Arilis Rojas, Lydia E Pace, Eileen Joyce, Esther Rhei, Rochelle Scheib, Brittany Bychkovsky, Judy E Garber, Daniel Morganstern, Tari A King
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk. Breast cancer research and treatment 175 (1) (2019)